Literature DB >> 1682637

Renal intratubular crystallisation of calcium oxalate and naftidrofuryl oxalate.

C Moesch, M Rince, M Daudon, J C Aldigier, C Leroux-Robert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1682637     DOI： 10.1016/0140-6736(91)92093-h

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Acute kidney injury associated with nafronyl oxalate overdose.

Authors:  Min Jee Kim; Ji Shin Lee; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2012-12-20       Impact factor: 2.801

Review 2.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

Review 3.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

Review 4.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Secondary Oxalate Nephropathy: A Systematic Review.

Authors:  Nuttha Lumlertgul; Monchai Siribamrungwong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-07-29

Review 6.  Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.

Authors:  T De Backer; R Vander Stichele; P Lehert; L Van Bortel
Journal:  BMJ       Date:  2009-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.